Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to observe the safety and effectiveness of transcatheter aortic valve replacement in patients with aortic valve stenosis in a real-world clinical practice environment.


Clinical Trial Description

This study is a prospective / retrospective, multicenterstudy after listing. The researchers preliminarily confirmed that they could be enrolled in this study according to the diagnosis of the subjects' medical history. After fully informed, they signed the informed consent, and met the TAVR inclusion requirements (see the inclusion criteria for details). At the same time, they registered the subjects in multiple centers. After the start of the trial, the participants were enrolled in the study, All the subjects who met the inclusion criteria but did not meet the discharge criteria were registered in the central registration system. The patients were followed up for 30 days, 6 months and 12 months, and followed up by telephone for 2, 3, 4 and 5 years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04988243
Study type Interventional
Source CCRF Inc., Beijing, China
Contact
Status Not yet recruiting
Phase N/A
Start date August 2021
Completion date August 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05552352 - VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease N/A
Recruiting NCT06168123 - Future Optimal Research and Care Evaluation - Aortic Stenosis
Active, not recruiting NCT05182307 - DurAVRâ„¢ THV System: First-In-Human Study N/A
Recruiting NCT06156592 - Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
Completed NCT04259723 - Virtual Reality Assisted Conscious Sedation During TAVI N/A
Recruiting NCT05873816 - The PROTEMBO Trial N/A
Recruiting NCT04128384 - Infranodal Conduction Time During TAVR as Predictor of HAVB N/A
Recruiting NCT05024942 - LUS in Aortic Stenosis Patients Undergoing TAVR
Recruiting NCT05283356 - Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Phase 4
Not yet recruiting NCT05847751 - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
Completed NCT02224066 - Platelet Reactivity After TAVI: A Multicenter Pilot Study Phase 4
Recruiting NCT06168370 - Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation N/A
Recruiting NCT05097183 - Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
Active, not recruiting NCT05712161 - Use of DurAVRâ„¢ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study N/A